特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子細胞遺伝学に基づく製品・サービスの市場 ~2021年:製品・技法 (In-Situ・FISH・比較ゲノムハイブリダイゼーション)・用途・エンドユーザー別

Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021

発行 MarketsandMarkets 商品コード 429379
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.17円で換算しております。
分子細胞遺伝学に基づく製品・サービスの市場 ~2021年:製品・技法 (In-Situ・FISH・比較ゲノムハイブリダイゼーション)・用途・エンドユーザー別 Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021
出版日: 2017年01月26日 ページ情報: 英文 150 Pages
概要

分子細胞遺伝学に基づく製品・サービスの市場は2016年から2021年にかけて10.1%のCAGR (年間複合成長率) で推移し、2016年の15億5000万米ドルから、2021年には25億2000万米ドルの規模に成長すると予測されています。

当レポートでは、世界の分子細胞遺伝学に基づく製品・サービスの市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、製品&サービス区分・技法・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

FIGURE 12 MOLECULAR CYTOGENETICS MARKET

第1章 イントロダクション

第2章 調査技法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 地域市場の分析:技法別
  • 市場規模:用途別

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 市場分析:製品別

  • イントロダクション
  • キット・試薬
    • 検査キット
    • プローブ
    • 蛍光アフィニティ試薬
    • その他
  • 機器
  • 消耗品
  • ソフトウェア&サービス

第7章 市場分析:技法別

  • イントロダクション
  • 比較ゲノムハイブリダイゼーション
    • アレイベースの比較ゲノムハイブリダイゼーション
    • 標準型比較ゲノムハイブリダイゼーション
  • 蛍光in situハイブリダイゼーション
  • in situハイブリダイゼーション
  • その他

第8章 市場分析:用途別

  • イントロダクション
  • 遺伝性疾患
  • パーソナライズドメディシン (個別化医療)
  • その他

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 臨床&研究ラボ
  • 学術研究機関
  • 医薬品・バイオテクノロジー企業
  • その他

第10章 市場分析:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域

第11章 競合環境

  • イントロダクション
  • 戦略概要
  • 市場シェア分析
  • 競合状況・動向
    • 提携・合意・協力
    • 新製品の投入
    • 買収
    • 拡張
    • その他

第12章 企業プロファイル

  • イントロダクション
  • ABBOTT LABORATORIES, INC.
  • AGILENT TECHNOLOGIES, INC.
  • APPLIED SPECTRAL IMAGING
  • BIO-RAD LABORATORIES, INC.
  • DANAHER CORPORATION
  • ILLUMINA, INC.
  • OXFORD GENE TECHNOLOGY (OGT)
  • PERKINELMER, INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • THERMO FISHER SCIENTIFIC INC.
    • 企業概要
    • 財務動向
    • 製品・サービス
    • 戦略
    • 近年の発展動向、など

第13章 付録

目次
Product Code: BT 4883

The molecular cytogenetics market is projected to reach USD 2.52 billion by 2021 from USD 1.55 billion in 2016, at a CAGR of 10.1% from 2016 to 2021.

The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. The kits and reagents segment is expected to register the highest growth rate in the molecular cytogenetics market, by product, during the forecast period. The high growth in this segment is attributed to the increasing number of rental agreements and increasing incidence of genetic disorders and cancer worldwide. However, the high cost of advanced instruments in emerging economies is restraining the growth of this market.

Based on end users, the molecular cytogenetics market is classified into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global molecular cytogenetics market in 2016. The large number of molecular cytogenetic tests performed in clinical and research laboratories will drive the growth of this market during the forecast period.

Geographically, North America dominates the global molecular cytogenetics market. Growth in the North American segment is primarily driven by the rapid growth in the aging population and increasing incidence of genetic disorders and cancer.

The major factors contributing to the growth of the global molecular cytogenetics market include the increasing incidence of genetic disorders and cancer, growing usage of molecular cytogenetic techniques in clinical pathological testing, and rising aging population. On the other hand, high cost of advanced instruments and unfavorable reimbursement scenario are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the molecular cytogenetics market.

The major players in the molecular cytogenetics market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Oxford Gene Technology (U.K.), and Applied Spectral Imaging (U.S.).

Research Coverage:

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the molecular cytogenetics market. The report analyses the molecular cytogenetics market by product, technique, application, and end user.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the molecular cytogenetics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the molecular cytogenetics market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for molecular cytogenetics across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the molecular cytogenetics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS COVERED
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR CYTOGENETICS: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: MOLECULAR CYTOGENETICS MARKET, BY TECHNIQUES
  • 4.3. MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Increasing incidences of genetic disorders and cancer
      • 5.2.1.2. Growing focus on targeted cancer treatment
      • 5.2.1.3. Increasing aging population and subsequent rise in prevalence of chronic diseases
      • 5.2.1.4. Increasing penetration of molecular cytogenetics in clinical pathological testing
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. High cost of advanced instruments
      • 5.2.2.2. Unfavourable reimbursement scenario
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Untapped emerging markets in Asia
    • 5.2.4. MARKET TRENDS
      • 5.2.4.1. Transition from FISH to array-based techniques

6. MOLECULAR CYTOGENETICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. KITS & REAGENTS
    • 6.2.1. TESTING KITS
    • 6.2.2. PROBES
    • 6.2.3. FLUORESCENT AFFINITY REAGENTS
    • 6.2.4. OTHER KITS & REAGENTS
  • 6.3. INSTRUMENTS
  • 6.4. CONSUMABLES
  • 6.5. SOFTWARE & SERVICES

7. MOLECULAR CYTOGENETICS MARKET, BY TECHNIQUE

  • 7.1. INTRODUCTION
  • 7.2. COMPARATIVE GENOMIC HYBRIDIZATION
    • 7.2.1. ARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION
    • 7.2.2. STANDARD COMPARATIVE GENOMIC HYBRIDIZATION
  • 7.3. FLUORESCENCE IN-SITU HYBRIDIZATION
  • 7.4. IN-SITU HYBRIDIZATION
  • 7.5. OTHER TECHNIQUES

8. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. GENETIC DISORDERS
  • 8.3. CANCER
  • 8.4. PERSONALIZED MEDICINE
  • 8.5. OTHER APPLICATIONS

9. MOLECULAR CYTOGENETICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL & RESEARCH LABORATORIES
  • 9.3. ACADEMIC RESEARCH INSTITUTES
  • 9.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 9.5. OTHER END USERS

10. MOLECULAR CYTOGENETICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. ROA
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. STRATEGIC OVERVIEW
  • 11.3. MARKET SHARE ANALYSIS
  • 11.4. COMPETITIVE SITUATION AND TRENDS
    • 11.4.1. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
    • 11.4.2. NEW PRODUCT LAUNCHES
    • 11.4.3. ACQUISITIONS
    • 11.4.4. EXPANSIONS
    • 11.4.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. ABBOTT LABORATORIES, INC.
  • 12.3. AGILENT TECHNOLOGIES, INC.
  • 12.4. APPLIED SPECTRAL IMAGING
  • 12.5. BIO-RAD LABORATORIES, INC.
  • 12.6. DANAHER CORPORATION
  • 12.7. ILLUMINA, INC.
  • 12.8. OXFORD GENE TECHNOLOGY (OGT)
  • 12.9. PERKINELMER, INC.
  • 12.10. F. HOFFMANN-LA ROCHE LTD.
  • 12.11. THERMO FISHER SCIENTIFIC INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PREVALENCE OF GENETIC DISORDERS (2012)
  • TABLE 2: INCIDENCE OF CANCER, BY COUNTRY (2012)
  • TABLE 3: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 4: MOLECULAR CYTOGENETICS KITS AND REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: MOLECULAR CYTOGENETICS KITS AND REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: MOLECULAR CYTOGENETICS MARKET SIZE FOR TESTING KITS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: MOLECULAR CYTOGENETICS MARKET SIZE FOR PROBES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: MOLECULAR CYTOGENETICS MARKET SIZE FOR FLUORESCENT AFFINITY REAGENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: MOLECULAR CYTOGENETICS MARKET SIZE FOR OTHER KITS AND REAGENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: MOLECULAR CYTOGENETICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: MOLECULAR CYTOGENETICS CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: MOLECULAR CYTOGENETICS SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 14: COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 16: ARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: STANDARD COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: FLUORESCENCE IN-SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: IN-SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: OTHER MOLECULAR CYTOGENETICS TECHNIQUES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE FOR GENETIC DISORDERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: MOLECULAR CYTOGENETICS MARKET SIZE FOR CANCER, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: MOLECULAR CYTOGENETICS MARKET SIZE FOR PERSONALIZED MEDICINE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: OTHER MOLECULAR CYTOGENETICS APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MOLECULAR CYTOGENETICS MARKET SIZE FOR CLINICAL AND RESEARCH LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: MOLECULAR CYTOGENETICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: MOLECULAR CYTOGENETICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: MOLECULAR CYTOGENETICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: LIST OF RELATED CONFERENCES HELD IN NORTH AMERICA
  • TABLE 33: NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 40: U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 41: U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 43: CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 45: CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 50: ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 53: ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 57: CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 58: CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 59: JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 60: JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 61: JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 63: INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 65: INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 67: ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 69: ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 73: ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 74: ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: GROWTH STRATEGY MATRIX, (2014-2016)
  • TABLE 76: COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2014-2016)
  • TABLE 77: NEW PRODUCT LAUNCHES (2014-2016)
  • TABLE 78: ACQUISITIONS (2014-2016)
  • TABLE 79: EXPANSIONS (2014-2016)
  • TABLE 80: OTHER DEVELOPMENTS (2014-2016)

LIST OF FIGURES

  • FIGURE 1: GLOBAL MOLECULAR CYTOGENETICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MOLECULAR CYTOGENETICS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: MOLECULAR CYTOGENETICS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GEOGRAPHIC SNAPSHOT OF THE GLOBAL MOLECULAR CYTOGENETICS MARKET
  • FIGURE 12: GLOBAL MOLECULAR CYTOGENETICS MARKET TO WITNESS DOUBLE-DIGIT GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: COMPARATIVE GENOMIC HYBRIDIZATION SEGMENT TO DOMINATE THE GLOBAL MOLECULAR CYTOGENETICS MARKET IN 2016
  • FIGURE 14: GENETIC DISORDERS SEGMENT WILL CONTINUE TO DOMINATE THE MOLECULAR CYTOGENETICS MARKET IN 2021
  • FIGURE 15: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: MOLECULAR CYTOGENETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
  • FIGURE 17: MOLECULAR CYTOGENETICS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 18: KITS AND REAGENTS WILL CONTINUE TO DOMINATE THE MOLECULAR CYTOGENETICS PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: COMPARATIVE GENOMIC HYBRIDIZATION TO DOMINATE THE MOLECULAR CYTOGENETICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: ARRAY-BASED CGH WILL CONTINUE TO DOMINATE THE CGH MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: GENETIC DISORDERS APPLICATIONS SEGMENT TO DOMINATE THE MOLECULAR CYTOGENETICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: CLINICAL AND RESEARCH LABORATORIES TO DOMINATE THE MOLECULAR CYTOGENETICS END-USER MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: MOLECULAR CYTOGENETICS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2016
  • FIGURE 24: MOLECULAR CYTOGENETICS MARKET IN EUROPE TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIGURE 26: U.S. TO DOMINATE THE NORTH AMERICAN MARKET IN 2016
  • FIGURE 27: KITS AND REAGENTS, THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET IN 2016
  • FIGURE 28: KITS & REAGENTS IS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN MOLECULAR CYTOGENETICS MARKET IN 2016
  • FIGURE 29: ASIA: MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIGURE 30: CHINA IS ESTIMATED TO DOMINATE THE ASIAN MOLECULAR CYTOGENETICS MARKET IN 2016
  • FIGURE 31: KITS AND REAGENTS TO GROW AT THE HIGHEST CAGR OF THE ASIAN MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016
  • FIGURE 32: KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE CHINESE MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016
  • FIGURE 33: KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE JAPANESE MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016
  • FIGURE 34: KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE INDIAN MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016
  • FIGURE 35: KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE ROA MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016
  • FIGURE 36: KITS AND REAGENTS SEGMENT TO GROW AT THE HIGHEST CAGR IN THE ROW MARKET
  • FIGURE 37: COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS WERE THE KEY STRATEGIES ADOPTED BY PLAYERS IN THE MOLECULAR CYTOGENETICS MARKET
  • FIGURE 38: MOLECULAR CYTOGENETICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 39: GEOGRAPHIC REVENUE MIX OF THE TOP MARKET PLAYERS
  • FIGURE 40: COMPANY SNAPSHOT: ABBOTT LABORATORIES, INC.
  • FIGURE 41: COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC.
  • FIGURE 42: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 43: COMPANY SNAPSHOT: DANHER CORPORATION
  • FIGURE 44: COMPANY SNAPSHOT: ILLUMINA, INC.
  • FIGURE 45: COMPANY SNAPSHOT: PERKINELMER, INC.
  • FIGURE 46: COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE LTD.
  • FIGURE 47: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.